Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Mereo BioPharma (MREO) EBT Margin (2023 - 2025)

Historic EBT Margin for Mereo BioPharma (MREO) over the last 2 years, with Q2 2025 value amounting to 2923.2%.

  • Mereo BioPharma's EBT Margin changed N/A to 2923.2% in Q2 2025 from the same period last year, while for Sep 2025 it was 12991.56%, marking a year-over-year decrease of 84067600.0%. This contributed to the annual value of 299.98% for FY2023, which is N/A changed from last year.
  • According to the latest figures from Q2 2025, Mereo BioPharma's EBT Margin is 2923.2%.
  • Over the past 5 years, Mereo BioPharma's EBT Margin peaked at 7159.44% during Q1 2025, and registered a low of 2923.2% during Q2 2025.